17021266	11421	Ye M	Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.	Journal of the American Society of Nephrology 	2006	65
24933400	11421	Bostick B	Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.	Metabolism	2014	22
11522676	11450	Maeda N	PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.	Diabetes	2001	227
11861525	11450	Combs TP	Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization.	Endocrinology	2002	94
12196466	11450	Nishizawa H	Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.	Diabetes	2002	95
12540596	11450	Combs TP	Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin.	Diabetes	2003	84
12802337	11450	Yamauchi T	Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.	Nature	2003	503
14624132	11450	Ouchi N	Obesity, adiponectin and vascular inflammatory disease.	Current opinion in lipidology	2003	135
15599400	11450	Furukawa S	Increased oxidative stress in obesity and its impact on metabolic syndrome.	The Journal of clinical investigation	2004	783
15897298	11450	Kadowaki T	Adiponectin and adiponectin receptors.	Endocrine reviews	2005	442
16306372	11450	Park SY	Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice.	Diabetes	2005	94
16567517	11450	Zvonic S	Characterization of peripheral circadian clocks in adipose tissues.	Diabetes	2006	131
17395738	11450	Hosogai N	Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation.	Diabetes	2007	268
18239070	11450	Sauter NS	The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia.	Endocrinology	2008	58
18326786	11450	Membrez M	Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.	FASEB journal 	2008	104
18375438	11450	Li M	Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance.	Diabetes	2008	103
18403477	11450	Weisberg SP	Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity.	Endocrinology	2008	53
18426778	11450	Peterson SJ	L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice.	Journal of lipid research	2008	69
18682512	11450	Aguilar-Salinas CA	High adiponectin concentrations are associated with the metabolically healthy obese phenotype.	The Journal of clinical endocrinology and metabolism	2008	54
19906806	11450	Ziemke F	Adiponectin in insulin resistance: lessons from translational research.	The American journal of clinical nutrition	2010	82
20858684	11450	Duval C	Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice.	Diabetes	2010	51
21346177	11450	Baldwin W	Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome.	Diabetes	2011	64
21515850	11450	McGillicuddy FC	Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.	Diabetes	2011	44
21723971	11450	Krings A	Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes.	Bone	2012	57
22315305	11450	Gunawardana SC	Reversal of type 1 diabetes in mice by brown adipose tissue transplant.	Diabetes	2012	46
22388319	11450	Qin F	The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice.	Circulation	2012	36
23334396	11450	Rutkowski JM	Adiponectin promotes functional recovery after podocyte ablation.	Journal of the American Society of Nephrology 	2013	30
23345456	11450	Anderson OS	Perinatal bisphenol A exposure promotes hyperactivity, lean body composition, and hormonal responses across the murine life course.	FASEB journal 	2013	27
23349501	11450	Neuhofer A	Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.	Diabetes	2013	28
23562077	11450	Mansuy-Aubert V	Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure.	Cell metabolism	2013	31
25339419	11450	Ye R	Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes β-cell regeneration.	eLife	2014	21
25576855	11450	Lecka-Czernik B	High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity.	Molecular and cellular endocrinology	2015	24
26417088	11450	Aye IL	Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
10856830	11545	Shall S	Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?	Mutation research	2000	120
11135624	11545	Garcia Soriano F	Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.	Nature medicine	2001	116
12440774	11545	Hassa PO	The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders.	Cellular and molecular life sciences 	2002	97
14523042	11545	Du X	Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.	The Journal of clinical investigation	2003	146
22923475	11545	Li G	Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice.	Diabetes	2012	31
10082470	11596	Schmidt AM	Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.	Circulation research	1999	113
11108954	11596	Schmidt AM	The biology of the receptor for advanced glycation end products and its ligands.	Biochimica et biophysica acta	2000	138
11287350	11596	Wautier MP	Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.	American journal of physiology. Endocrinology and metabolism	2001	148
14623906	11596	Chavakis T	The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment.	The Journal of experimental medicine	2003	124
16133426	11596	Bierhaus A	Understanding RAGE, the receptor for advanced glycation end products.	Journal of molecular medicine	2005	236
18511846	11596	Soro-Paavonen A	Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.	Diabetes	2008	95
20627935	11596	Reiniger N	Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse.	Diabetes	2010	44
23838007	11596	Xie J	Cellular signalling of the receptor for advanced glycation end products (RAGE).	Cellular signalling	2013	52
24520121	11596	Song F	RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice.	Diabetes	2014	25
17615264	11600	Wu Y	Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.	Stem cells	2007	308
21606590	11600	Jeansson M	Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.	The Journal of clinical investigation	2011	97
24009238	11600	Dessapt-Baradez C	Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.	Journal of the American Society of Nephrology 	2014	21
17023536	11604	Xu AW	Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding.	Endocrinology	2007	65
22682251	11604	Ren H	FoxO1 target Gpr17 activates AgRP neurons to regulate food intake.	Cell	2012	54
24462248	11604	Vogt MC	Neonatal insulin action impairs hypothalamic neurocircuit formation in response to maternal high-fat feeding.	Cell	2014	47
25915476	11604	Garfield AS	A neural basis for melanocortin-4 receptor-regulated appetite.	Nature neuroscience	2015	43
27015310	11604	Steculorum SM	AgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue.	Cell	2016	14
15118095	11606	Paterson JM	Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2004	81
17977949	11606	Brezniceanu ML	Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells.	Diabetes	2008	54
18025412	11606	Santos SH	Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.	Diabetes	2008	52
18838678	11606	Zhang Z	Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.	Proceedings of the National Academy of Sciences of the United States of America	2008	76
20676904	11606	Marsh SA	Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.	Amino acids	2011	38
22493070	11606	Briones AM	Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction.	Hypertension	2012	53
25552600	11606	Vasamsetti SB	Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis.	Diabetes	2015	34
12376594	11634	Anderson MS	Projection of an immunological self shadow within the thymus by the aire protein.	Science	2002	514
15492124	11634	Liston A	Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity.	The Journal of experimental medicine	2004	80
17116738	11634	DeVoss J	Spontaneous autoimmunity prevented by thymic expression of a single self-antigen.	The Journal of experimental medicine	2006	106
22552229	11634	Taniguchi RT	Detection of an autoreactive T-cell population within the polyclonal repertoire that undergoes distinct autoimmune regulator (Aire)-mediated selection.	Proceedings of the National Academy of Sciences of the United States of America	2012	37
23993652	11634	Gardner JM	Extrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4⁺ T cells.	Immunity	2013	32
11544177	11651	Chen WS	Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.	Genes and development	2001	253
11590437	11651	Tuttle RL	Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.	Nature medicine	2001	151
11733558	11651	Bernal-Mizrachi E	Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia.	The Journal of clinical investigation	2001	127
12791994	11651	Du K	TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver.	Science	2003	234
15033922	11651	Ho L	Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.	FASEB journal 	2004	144
15467831	11651	Bernal-Mizrachi E	Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells.	The Journal of clinical investigation	2004	86
15485899	11651	Lai KM	Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy.	Molecular and cellular biology	2004	108
15509553	11651	Nakatani Y	Involvement of endoplasmic reticulum stress in insulin resistance and diabetes.	The Journal of biological chemistry	2005	123
15632167	11651	Yasukawa T	S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance.	The Journal of biological chemistry	2005	84
15793233	11651	Carvalho-Filho MA	S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance.	Diabetes	2005	74
16446424	11651	Furuya F	Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.	Proceedings of the National Academy of Sciences of the United States of America	2006	63
16453021	11651	Anitha M	GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway.	The Journal of clinical investigation	2006	73
18276596	11651	Taylor EB	Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle.	The Journal of biological chemistry	2008	74
19122674	11651	Luan B	Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance.	Nature	2009	53
19147655	11651	Wright JJ	Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.	Cardiovascular research	2009	49
19151200	11651	Noyan-Ashraf MH	GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.	Diabetes	2009	109
19153269	11651	Sun Q	Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity.	Circulation	2009	128
20068149	11651	Novosyadlyy R	Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.	Cancer research	2010	89
21161163	11651	Yu Z	Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 corrected(NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice.	Diabetologia	2011	37
21441927	11651	Jordan SD	Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism.	Nature cell biology	2011	105
21709230	11651	Soltani N	GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2011	53
21965330	11651	Wang RH	Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.	The Journal of clinical investigation	2011	86
22344295	11651	Lu M	Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.	Nature medicine	2012	75
22773877	11651	Yuan M	Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.	The Journal of biological chemistry	2012	43
24490809	11651	Zeng Y	The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms.	Cardiovascular diabetology	2014	22
25446031	11651	Busada JT	Retinoic acid regulates Kit translation during spermatogonial differentiation in the mouse.	Developmental biology	2015	15
26136189	11651	Chen JA	Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.	Journal of cachexia, sarcopenia and muscle	2015	16
26626461	11651	Szabat M	Reduced Insulin Production Relieves Endoplasmic Reticulum Stress and Induces β Cell Proliferation.	Cell metabolism	2016	13
12843127	11652	Garofalo RS	Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta.	The Journal of clinical investigation	2003	210
16804077	11652	Kramer HF	Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle.	Diabetes	2006	85
19883618	11652	Leavens KF	Akt2 is required for hepatic lipid accumulation in models of insulin resistance.	Cell metabolism	2009	84
17130477	11677	Drel VR	The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.	Diabetes	2006	73
17626889	11677	Obrosova IG	High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition.	Diabetes	2007	82
18346986	11687	Gubitosi-Klug RA	5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy.	Diabetes	2008	52
18780776	11687	Nunemaker CS	12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet.	American journal of physiology. Endocrinology and metabolism	2008	53
19521344	11687	Chakrabarti SK	12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes.	Obesity	2009	55
8910278	11770	Hotamisligil GS	Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.	Science	1996	158
14500573	11770	Rzonca SO	Bone is a target for the antidiabetic compound rosiglitazone.	Endocrinology	2004	109
16054052	11770	Maeda K	Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.	Cell metabolism	2005	118
17259372	11770	Wright WS	Wnt10b inhibits obesity in ob/ob and agouti mice.	Diabetes	2007	63
17554340	11770	Furuhashi M	Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.	Nature	2007	153
23991091	11770	Miller AM	MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.	PloS one	2013	32
24319114	11770	Garin-Shkolnik T	FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues.	Diabetes	2014	21
9734395	11816	Park L	Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts.	Nature medicine	1998	211
10521365	11816	Huber SA	Interleukin-6 exacerbates early atherosclerosis in mice.	Arteriosclerosis, thrombosis, and vascular biology	1999	98
12431986	11816	Yamauchi T	Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.	The Journal of biological chemistry	2003	169
12451010	11816	Bucciarelli LG	RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.	Circulation	2002	111
14597759	11816	Bruemmer D	Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.	The Journal of clinical investigation	2003	82
14744975	11816	Paul A	C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2004	71
16103409	11816	Hermanowski-Vosatka A	11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.	The Journal of experimental medicine	2005	74
17420349	11816	Lewis P	Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.	Circulation	2007	67
17942401	11816	Cao D	Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease.	The Journal of biological chemistry	2007	83
17991878	11816	Okamoto Y	Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.	Circulation research	2008	63
20068138	11816	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	96
20444418	11816	Rask-Madsen C	Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice.	Cell metabolism	2010	80
20460915	11816	Trauner M	Bile acids as regulators of hepatic lipid and glucose metabolism.	Digestive diseases	2010	58
20817865	11816	Kyaw T	Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.	Journal of immunology	2010	62
20854843	11816	Hauser PS	Apolipoprotein E: from lipid transport to neurobiology.	Progress in lipid research	2011	54
21278760	11816	Tlaskalová-Hogenová H	The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.	Cellular and molecular immunology	2011	102
21356305	11816	Drake C	Brain inflammation is induced by co-morbidities and risk factors for stroke.	Brain, behavior, and immunity	2011	53
21868694	11816	Kyaw T	B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.	Circulation research	2011	68
22007077	11816	Shah Z	Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.	Circulation	2011	72
22240132	11816	Matsubara J	A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.	Journal of the American College of Cardiology	2012	61
22469977	11816	Alikhani N	Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model.	Oncogene	2013	28
23341580	11816	Jansen F	High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.	Cardiovascular research	2013	29
23564668	11816	Gray SP	NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.	Circulation	2013	76
26322175	11816	Husain K	Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.	World journal of biological chemistry	2015	18
26715682	11816	Gray SP	Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.	Arteriosclerosis, thrombosis, and vascular biology	2016	15
27737949	11816	Wang Q	Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission.	Diabetes	2017	6
11773613	11827	Nielsen S	Aquaporins in the kidney: from molecules to medicine.	Physiological reviews	2002	205
20562852	11865	Marcheva B	Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes.	Nature	2010	318
21966465	11865	Shimba S	Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation.	PloS one	2011	57
22611086	11865	Guo B	The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway.	FASEB journal 	2012	30
23434278	11865	Shi SQ	Circadian disruption leads to insulin resistance and obesity.	Current biology 	2013	72
23434933	11865	Shostak A	Circadian regulation of lipid mobilization in white adipose tissues.	Diabetes	2013	28
23547261	11865	Lee J	Bmal1 and β-cell clock are required for adaptation to circadian disruption, and their loss of function leads to oxidative stress-induced β-cell failure in mice.	Molecular and cellular biology	2013	39
26542580	11865	Perelis M	Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion.	Science	2015	32
26554015	11865	Atger F	Circadian and feeding rhythms differentially affect rhythmic mRNA transcription and translation in mouse liver.	Proceedings of the National Academy of Sciences of the United States of America	2015	23
15199129	11910	Hartman MG	Role for activating transcription factor 3 in stress-induced beta-cell apoptosis.	Molecular and cellular biology	2004	87
16246168	11910	Wek RC	Coping with stress: eIF2 kinases and translational control.	Biochemical Society transactions	2006	412
17785797	11910	Whitmore MM	Negative regulation of TLR-signaling pathways by activating transcription factor-3.	Journal of immunology	2007	58
19254572	11910	Qi L	Adipocyte CREB promotes insulin resistance in obesity.	Cell metabolism	2009	53
22228718	11911	Zhong Y	Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell-derived inflammatory cytokine production in diabetes.	Diabetes	2012	40
22692209	11911	Ebert SM	Stress-induced skeletal muscle Gadd45a expression reprograms myonuclei and causes muscle atrophy.	The Journal of biological chemistry	2012	36
23941879	11911	Bongers KS	Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4.	American journal of physiology. Endocrinology and metabolism	2013	29
25170079	11911	Jiang S	Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis.	The Journal of biological chemistry	2014	25
10677506	11925	Gradwohl G	neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas.	Proceedings of the National Academy of Sciences of the United States of America	2000	392
15604203	11925	Habener JF	Minireview: transcriptional regulation in pancreatic development.	Endocrinology	2005	103
17804764	11925	Lynn FC	MicroRNA expression is required for pancreatic islet cell genesis in the mouse.	Diabetes	2007	111
18243096	11925	Xu X	Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas.	Cell	2008	305
19289082	11925	Yechoor V	Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes.	Developmental cell	2009	67
19487809	11925	Oliver-Krasinski JM	The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice.	The Journal of clinical investigation	2009	46
22406641	11925	Talchai C	Generation of functional insulin-producing cells in the gut by Foxo1 ablation.	Nature genetics	2012	38
22980982	11925	Talchai C	Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.	Cell	2012	257
24240391	11925	Baeyens L	Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice.	Nature biotechnology	2014	54
19280661	12064	Stranahan AM	Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice.	Hippocampus	2009	104
19387610	12064	Matthews VB	Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase.	Diabetologia	2009	61
20162412	12064	Sasaki M	Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.	Diabetologia	2010	50
20670674	12064	Park HR	A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor.	Neuroscience letters	2010	44
22508336	12064	Sharma S	Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry.	International journal of obesity	2013	47
23229740	12064	Sharma S	Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal.	International journal of obesity	2013	32
25344694	12064	Lin B	Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.	Cardiovascular diabetology	2014	22
17053023	12097	Botolin S	Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice.	Endocrinology	2007	61
18362359	12097	Ferron M	Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	178
21550430	12097	Ferron M	Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice.	Bone	2012	62
8720919	12359	Lenzen S	Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues.	Free radical biology and medicine	1996	174
19265038	12359	Collins AR	Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.	Circulation research	2009	77
22315314	12359	Hwang I	Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction.	Diabetes	2012	30
23204527	12359	Rindler PM	High dietary fat selectively increases catalase expression within cardiac mitochondria.	The Journal of biological chemistry	2013	25
17192486	12362	Vincent JA	Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia.	Diabetes	2007	71
19494813	12362	Guarda G	T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes.	Nature	2009	73
21217695	12362	Vandanmagsar B	The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.	Nature medicine	2011	439
21270263	12362	Koenen TB	Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue.	Diabetes	2011	40
24194505	12362	Mirza RE	Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice.	Diabetes	2014	24
24222351	12362	Westwell-Roper CY	Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.	Diabetes	2014	22
25075770	12362	Shahzad K	Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy.	Kidney international	2015	35
12031984	12367	Cai L	Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway.	Diabetes	2002	111
15326158	12367	Martin PM	Death of retinal neurons in streptozotocin-induced diabetic mice.	Investigative ophthalmology and visual science	2004	120
16249509	12367	Feit-Leichman RA	Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.	Investigative ophthalmology and visual science	2005	75
16380497	12367	Susztak K	Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.	Diabetes	2006	261
17045908	12367	Cai L	Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.	Journal of the American College of Cardiology	2006	85
19676126	12367	Witek RP	Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.	Hepatology	2009	61
25963822	12367	Nishimura S	IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs.	The Journal of cell biology	2015	16
12724780	12477	Ueda H	Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.	Nature	2003	410
15468055	12477	Tang Q	Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function.	European journal of immunology	2004	107
19109158	12477	Schmidt EM	Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity.	Journal of immunology	2009	48
19426214	12477	Bour-Jordan H	Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.	Immunological reviews	2009	75
20679400	12477	Grinberg-Bleyer Y	IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells.	The Journal of experimental medicine	2010	102
24323581	12477	Han JM	Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity.	Journal of immunology	2014	22
24676639	12477	Fiorina P	Role of podocyte B7-1 in diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	27
25329329	12477	Schubert D	Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.	Nature medicine	2014	67
25548162	12477	Wang CJ	CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement.	Proceedings of the National Academy of Sciences of the United States of America	2015	19
10795741	12487	Salomon B	B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.	Immunity	2000	503
14500627	12487	Tang Q	Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.	Journal of immunology	2003	165
15184499	12487	Tang Q	In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.	The Journal of experimental medicine	2004	293
23858035	12487	de Kouchkovsky D	microRNA-17-92 regulates IL-10 production by regulatory T cells and control of experimental autoimmune encephalomyelitis.	Journal of immunology	2013	32
25680271	12487	DuPage M	The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.	Immunity	2015	23
27192564	12487	Esensten JH	CD28 Costimulation: From Mechanism to Therapy.	Immunity	2016	16
15841205	12491	Drover VA	CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood.	The Journal of clinical investigation	2005	72
17363697	12491	Yang J	CD36 deficiency rescues lipotoxic cardiomyopathy.	Circulation research	2007	61
17728375	12491	Koonen DP	Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.	Diabetes	2007	82
18840358	12491	Schwartz GJ	The lipid messenger OEA links dietary fat intake to satiety.	Cell metabolism	2008	80
21803601	12491	Mirza R	Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice.	Cytokine	2011	47
23197723	12491	Yamanaka M	PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.	The Journal of neuroscience 	2012	68
23812099	12491	Sheedy FJ	CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.	Nature immunology	2013	117
8278351	12501	Chatenoud L	Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.	Proceedings of the National Academy of Sciences of the United States of America	1994	144
12937416	12501	Belghith M	TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.	Nature medicine	2003	162
16628253	12501	Bresson D	Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.	The Journal of clinical investigation	2006	94
17130466	12501	Sherry NA	Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes.	Diabetes	2006	69
17389382	12501	You S	Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.	Proceedings of the National Academy of Sciences of the United States of America	2007	61
17641665	12501	Chatenoud L	CD3-specific antibodies: a portal to the treatment of autoimmunity.	Nature reviews. Immunology	2007	108
20445103	12501	Ilan Y	Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice.	Proceedings of the National Academy of Sciences of the United States of America	2010	62
11793013	12504	Eizirik DL	A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis.	Diabetologia	2001	162
12949259	12504	Green EA	CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2003	96
15184500	12504	Tarbell KV	CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.	The Journal of experimental medicine	2004	182
15534371	12504	van Santen HM	Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells.	The Journal of experimental medicine	2004	80
15837817	12504	Pop SM	Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.	The Journal of experimental medicine	2005	67
15855328	12504	You S	Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells.	Diabetes	2005	75
15897273	12504	Obst R	Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response.	The Journal of experimental medicine	2005	112
16311599	12504	Tang Q	Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice.	Nature immunology	2006	249
17142730	12504	Battaglia M	Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.	Journal of immunology	2006	192
17210729	12504	Tarbell KV	Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.	The Journal of experimental medicine	2007	116
17307871	12504	Luo X	Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.	Proceedings of the National Academy of Sciences of the United States of America	2007	78
17327428	12504	Mallone R	CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.	Diabetes	2007	65
17349009	12504	Di Lorenzo TP	Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.	Clinical and experimental immunology	2007	88
17911589	12504	Saxena V	The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse.	Journal of immunology	2007	60
19289457	12504	Emamaullee JA	Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.	Diabetes	2009	94
19421731	12504	Madec AM	Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.	Diabetologia	2009	63
19500966	12504	Zhou X	Plasticity of CD4(+) FoxP3(+) T cells.	Current opinion in immunology	2009	114
19818656	12504	Lennon GP	T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.	Immunity	2009	58
19922665	12504	Toapanta FR	Impaired immune responses in the lungs of aged mice following influenza infection.	Respiratory research	2009	64
20956337	12504	Yin B	Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.	Journal of immunology	2010	42
21099113	12504	Grinberg-Bleyer Y	Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.	The Journal of clinical investigation	2010	41
21709219	12504	Kriegel MA	Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice.	Proceedings of the National Academy of Sciences of the United States of America	2011	132
21911743	12504	Eller K	Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy.	Diabetes	2011	54
22596049	12504	Bertola A	Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients.	Diabetes	2012	55
22688334	12504	Bassi ÊJ	Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.	Diabetes	2012	35
24663679	12504	Ferreira GB	1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice.	Journal of immunology	2014	20
25367577	12504	Ferris ST	A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.	Immunity	2014	31
25659269	12504	Rodriguez-Del Rio E	A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.	Vaccine	2015	17
25970503	12504	Candon S	Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.	PloS one	2015	26
26154056	12504	Garidou L	The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease.	Cell metabolism	2015	21
26321681	12504	Ho PC	Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.	Cell	2015	96
26912858	12504	Delong T	Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion.	Science	2016	29
12228220	12702	Rui L	SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.	The Journal of biological chemistry	2002	211
12560330	12702	Senn JJ	Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.	The Journal of biological chemistry	2003	104
15240880	12702	Ueki K	Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse.	Proceedings of the National Academy of Sciences of the United States of America	2004	79
20068134	12702	Reed AS	Functional role of suppressor of cytokine signaling 3 upregulation in hypothalamic leptin resistance and long-term energy homeostasis.	Diabetes	2010	41
22961088	12702	Jorgensen SB	Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity.	Diabetes	2013	34
26366710	12702	Ortega-Molina A	The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.	Nature medicine	2015	24
16341265	12772	Weisberg SP	CCR2 modulates inflammatory and metabolic effects of high-fat feeding.	The Journal of clinical investigation	2006	425
18829989	12772	Lumeng CN	Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes.	Diabetes	2008	207
20103702	12772	Obstfeld AE	C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.	Diabetes	2010	65
21983520	12772	Leuschner F	Therapeutic siRNA silencing in inflammatory monocytes in mice.	Nature biotechnology	2011	160
22190646	12772	Oh DY	Increased macrophage migration into adipose tissue in obese mice.	Diabetes	2012	83
22719068	12772	Movahedi K	Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.	Cancer research	2012	39
25315009	12772	Morinaga H	Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice.	Diabetes	2015	15
18378574	13058	Al-Shabrawey M	Role of NADPH oxidase in retinal vascular inflammation.	Investigative ophthalmology and visual science	2008	64
22549734	13058	Youn JY	The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.	Diabetologia	2012	31
23349484	13058	Sukumar P	Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction.	Diabetes	2013	30
25529920	13058	Jaishy B	Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity.	Journal of lipid research	2015	16
11526215	13198	Oyadomari S	Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway.	Proceedings of the National Academy of Sciences of the United States of America	2001	148
11854325	13198	Oyadomari S	Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes.	The Journal of clinical investigation	2002	273
18776938	13198	Song B	Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes.	The Journal of clinical investigation	2008	200
21284983	13198	Wu J	The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex.	Cell metabolism	2011	57
17510710	13350	Liu L	Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance.	The Journal of clinical investigation	2007	111
18757836	13350	Yen CL	Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.	Journal of lipid research	2008	188
15561913	13482	Winzell MS	The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.	Diabetes	2004	197
16731832	13482	Mu J	Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.	Diabetes	2006	97
20097729	13482	Sauvé M	Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.	Diabetes	2010	62
21330637	13482	Shirakawa J	Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.	Diabetes	2011	45
24574044	13482	Kanasaki K	Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.	Diabetes	2014	41
24836562	13482	Smith EP	The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.	Cell metabolism	2014	29
24843641	13482	Seino Y	Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.	Journal of diabetes investigation	2013	32
16754860	13982	Le May C	Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	85
18256928	13982	Phoenix KN	Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	Breast cancer research and treatment	2009	46
19164473	13982	Riant E	Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice.	Endocrinology	2009	81
19587358	13982	Liu S	Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival.	Diabetes	2009	54
19920214	13982	Ribas V	Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice.	American journal of physiology. Endocrinology and metabolism	2010	70
21245576	13982	Park CJ	Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice.	The Journal of clinical investigation	2011	49
21747171	13982	Tiano JP	Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes.	The Journal of clinical investigation	2011	45
21900603	13982	Ribas V	Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
22966069	13982	Zhu L	Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance.	Diabetes	2013	43
24049737	13982	Davis KE	The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis.	Molecular metabolism	2013	37
25373903	13982	Morselli E	Hypothalamic PGC-1α protects against high-fat diet exposure by regulating ERα.	Cell reports	2014	29
21270273	14268	Kitada M	Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway.	Diabetes	2011	63
22223877	14268	Putta S	Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.	Journal of the American Society of Nephrology 	2012	78
25656366	14268	Gorin Y	Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.	American journal of physiology. Renal physiology	2015	23
11557972	14377	Yoon JC	Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.	Nature	2001	467
17360978	14377	Zhang Y	Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms.	Diabetes	2007	98
26403433	14377	Xin C	Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway.	International journal of obesity	2016	11
17143333	14378	Krishnamurthy B	Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.	The Journal of clinical investigation	2006	69
8232539	14417	Tisch R	Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.	Nature	1993	167
10905482	14526	Stoffers DA	Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.	Diabetes	2000	94
17724330	14526	Jang HJ	Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.	Proceedings of the National Academy of Sciences of the United States of America	2007	219
18519800	14526	Edfalk S	Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion.	Diabetes	2008	106
18796545	14526	Zhou J	Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.	American journal of physiology. Endocrinology and metabolism	2008	75
19041768	14526	Reimann F	Glucose sensing in L cells: a primary cell study.	Cell metabolism	2008	169
19221011	14526	Ma J	Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects.	American journal of physiology. Gastrointestinal and liver physiology	2009	55
19265026	14526	Rankin MM	Adaptive beta-cell proliferation is severely restricted with advanced age.	Diabetes	2009	125
20522593	14526	Hisadome K	Leptin directly depolarizes preproglucagon neurons in the nucleus tractus solitarius: electrical properties of glucagon-like Peptide 1 neurons.	Diabetes	2010	47
21209017	14526	Tolhurst G	Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP.	Endocrinology	2011	38
21411304	14526	Neyrinck AM	Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.	The Journal of nutritional biochemistry	2012	38
21444924	14526	Tian G	Glucose- and hormone-induced cAMP oscillations in α- and β-cells within intact pancreatic islets.	Diabetes	2011	37
21487412	14526	Teramoto S	Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia.	Journal of cerebral blood flow and metabolism 	2011	42
22037645	14526	Ellingsgaard H	Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.	Nature medicine	2011	119
22933116	14526	Lockie SH	Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling.	Diabetes	2012	42
22938097	14526	Hölscher C	Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection.	CNS drugs	2012	31
23142820	14526	Finan B	Targeted estrogen delivery reverses the metabolic syndrome.	Nature medicine	2012	39
24296712	14526	Richards P	Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model.	Diabetes	2014	45
24762441	14526	Sisley S	Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.	The Journal of clinical investigation	2014	46
25109781	14526	Psichas A	The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents.	International journal of obesity	2015	33
25303528	14526	Yore MM	Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.	Cell	2014	58
25894829	14526	Bonner C	Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.	Nature medicine	2015	47
27390011	14526	Adriaenssens AE	Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets.	Diabetologia	2016	11
12552113	14527	Gelling RW	Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	128
17131145	14527	Conarello SL	Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.	Diabetologia	2007	56
19602537	14527	Pocai A	Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.	Diabetes	2009	48
22214853	14527	Unger RH	Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.	The Journal of clinical investigation	2012	116
23305646	14527	Habegger KM	Fibroblast growth factor 21 mediates specific glucagon actions.	Diabetes	2013	26
25675519	14527	Wang MY	Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway.	Proceedings of the National Academy of Sciences of the United States of America	2015	17
12068290	14607	Miyawaki K	Inhibition of gastric inhibitory polypeptide signaling prevents obesity.	Nature medicine	2002	123
12409292	14652	Li Y	Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.	The Journal of biological chemistry	2003	118
17084712	14652	Yusta B	GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress.	Cell metabolism	2006	97
17187081	14652	Hansotia T	Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.	The Journal of clinical investigation	2007	58
17213325	14652	Knudsen LB	Small-molecule agonists for the glucagon-like peptide 1 receptor.	Proceedings of the National Academy of Sciences of the United States of America	2007	56
18427132	14652	Ban K	Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.	Circulation	2008	195
19164583	14652	Li Y	GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.	Proceedings of the National Academy of Sciences of the United States of America	2009	99
19957161	14652	Hsieh J	The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice.	Diabetologia	2010	41
20972533	14652	Maida A	Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.	Diabetologia	2011	47
23434938	14652	Wilson-Pérez HE	Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency.	Diabetes	2013	54
23542788	14652	Kim M	GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.	Nature medicine	2013	66
24152968	14652	Fujita H	The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential.	Kidney international	2014	26
24917578	14652	Beiroa D	GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.	Diabetes	2014	56
11588148	14683	Weinstein LS	Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.	Endocrine reviews	2001	91
19037247	15183	Alenghat T	Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology.	Nature	2008	97
21393543	15183	Feng D	A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism.	Science	2011	191
22156208	15183	Mullican SE	Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation.	Genes and development	2011	54
22561686	15183	Sun Z	Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration.	Nature medicine	2012	83
23069623	15183	Galmozzi A	Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue.	Diabetes	2013	34
23192980	15183	Mullican SE	A novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods.	Molecular endocrinology	2013	31
23292142	15183	You SH	Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo.	Nature structural and molecular biology	2013	42
24268577	15183	Sun Z	Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.	Molecular cell	2013	53
18397542	15251	Trayhurn P	Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?	The British journal of nutrition	2008	82
19057015	15251	Botusan IR	Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	75
19065050	15251	Cantley J	Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice.	The Journal of clinical investigation	2009	50
20141841	15251	Zhong L	The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.	Cell	2010	241
20332345	15251	Li J	Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.	Diabetes	2010	53
22302938	15251	Krishnan J	Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system.	Genes and development	2012	61
23249949	15251	Sun K	Selective inhibition of hypoxia-inducible factor 1α ameliorates adipose tissue dysfunction.	Molecular and cellular biology	2013	34
26203118	15251	You YH	Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease.	Journal of the American Society of Nephrology 	2016	19
18926825	15368	Choi KM	Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis.	Gastroenterology	2008	66
20178793	15368	Choi KM	CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice.	Gastroenterology	2010	51
24995976	15368	Jais A	Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man.	Cell	2014	41
11739957	15483	Masuzaki H	A transgenic model of visceral obesity and the metabolic syndrome.	Science	2001	255
15047607	15483	Morton NM	Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.	Diabetes	2004	84
12941770	15874	Butler AE	Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.	Diabetes	2003	93
25700985	15874	Oskarsson ME	In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.	The American journal of pathology	2015	25
15231732	15894	Joussen AM	A central role for inflammation in the pathogenesis of diabetic retinopathy.	FASEB journal 	2004	278
17962481	15894	Leal EC	Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.	Investigative ophthalmology and visual science	2007	67
24067647	15894	Du Y	Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina.	Proceedings of the National Academy of Sciences of the United States of America	2013	56
18195074	15978	Jain R	Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production.	The Journal of experimental medicine	2008	71
19130584	15978	Martin-Orozco N	Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells.	European journal of immunology	2009	115
19633655	15978	Liu J	Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.	Nature medicine	2009	175
20381385	15978	Tsai S	Reversal of autoimmunity by boosting memory-like autoregulatory T cells.	Immunity	2010	73
11739335	16000	Nakae J	Distinct and overlapping functions of insulin and IGF-I receptors.	Endocrine reviews	2001	115
12235108	16000	Yakar S	Circulating levels of IGF-1 directly regulate bone growth and density.	The Journal of clinical investigation	2002	177
16530517	16000	Horváth VJ	Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis.	Gastroenterology	2006	63
16642022	16000	Ueki K	Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes.	Nature genetics	2006	77
17416680	16000	Okada T	Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2007	92
22021391	16000	Bailey-Downs LC	Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2012	50
22692545	16000	Boucher J	Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling.	Nature communications	2012	37
23591370	16000	Junnila RK	The GH/IGF-1 axis in ageing and longevity.	Nature reviews. Endocrinology	2013	61
23771523	16000	Quinn BJ	Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.	Cancer prevention research	2013	26
25619689	16000	Hofmann JW	Reduced expression of MYC increases longevity and enhances healthspan.	Cell	2015	30
26094889	16000	Brandhorst S	A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan.	Cell metabolism	2015	53
11489937	16150	Kim JK	Prevention of fat-induced insulin resistance by salicylate.	The Journal of clinical investigation	2001	152
15479644	16150	Cai D	IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.	Cell	2004	323
15685170	16150	Arkan MC	IKK-beta links inflammation to obesity-induced insulin resistance.	Nature medicine	2005	470
15685173	16150	Cai D	Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.	Nature medicine	2005	490
19683471	16150	Tanti JF	Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation.	Current opinion in pharmacology	2009	87
21784844	16150	Meng Q	Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)/NF-kappaB pathway.	The Journal of biological chemistry	2011	52
22940906	16150	Li J	IKKβ/NF-κB disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes.	Nature cell biology	2012	62
25617315	16150	Clarke JR	Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation.	EMBO molecular medicine	2015	17
17878382	16176	Wu D	Aging up-regulates expression of inflammatory mediators in mouse adipose tissue.	Journal of immunology	2007	85
19208854	16176	Jeong HW	Berberine suppresses proinflammatory responses through AMPK activation in macrophages.	American journal of physiology. Endocrinology and metabolism	2009	96
20086228	16176	Roggli E	Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.	Diabetes	2010	78
23493576	16176	Mirza RE	Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes.	Diabetes	2013	29
24523551	16176	Erion JR	Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity.	The Journal of neuroscience 	2014	46
25288672	16176	Padgett LE	Loss of NADPH oxidase-derived superoxide skews macrophage phenotypes to delay type 1 diabetes.	Diabetes	2015	16
25626736	16176	Finucane OM	Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesity.	Diabetes	2015	22
28092375	16176	Dror E	Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation.	Nature immunology	2017	5
12453891	16193	Senn JJ	Interleukin-6 induces cellular insulin resistance in hepatocytes.	Diabetes	2002	127
14578297	16193	Klover PJ	Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice.	Diabetes	2003	92
15047622	16193	Kim HJ	Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.	Diabetes	2004	113
16581004	16193	Inoue H	Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.	Cell metabolism	2006	88
17579207	16193	Ehses JA	Increased number of islet-associated macrophages in type 2 diabetes.	Diabetes	2007	121
18510618	16193	Wieckowska A	Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.	The American journal of gastroenterology	2008	102
19801514	16193	Turner MS	Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.	Journal of immunology	2009	61
20697689	16193	Matthews VB	Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance.	Diabetologia	2010	74
20956499	16193	Rytka JM	The portal theory supported by venous drainage-selective fat transplantation.	Diabetes	2011	40
21478260	16193	Hellmann J	Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.	FASEB journal 	2011	70
23049932	16193	Pettersson US	Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue.	PloS one	2012	56
23221344	16193	Stanford KI	Brown adipose tissue regulates glucose homeostasis and insulin sensitivity.	The Journal of clinical investigation	2013	152
24416310	16193	Knudsen JG	Role of IL-6 in exercise training- and cold-induced UCP1 expression in subcutaneous white adipose tissue.	PloS one	2014	22
24681566	16193	Mauer J	Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin.	Nature immunology	2014	80
25352637	16193	Fuster JJ	Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion.	Diabetes	2015	19
15220196	16333	Tang DQ	In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow.	Diabetes	2004	78
19680229	16333	Fan Y	Thymus-specific deletion of insulin induces autoimmune diabetes.	The EMBO journal	2009	55
22074781	16333	Akirav EM	Detection of β cell death in diabetes using differentially methylated circulating DNA.	Proceedings of the National Academy of Sciences of the United States of America	2011	53
9133560	16334	Yoshioka M	A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice.	Diabetes	1997	165
9884331	16334	Wang J	A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse.	The Journal of clinical investigation	1999	173
15889095	16334	Nakayama M	Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.	Nature	2005	201
15914643	16334	Barber AJ	The Ins2Akita mouse as a model of early retinal complications in diabetes.	Investigative ophthalmology and visual science	2005	145
17855560	16334	Støy J	Insulin gene mutations as a cause of permanent neonatal diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2007	134
20825366	16334	Chacko BK	Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ.	The Biochemical journal	2010	60
21841312	16334	Wei FY	Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice.	The Journal of clinical investigation	2011	60
22915034	16334	Muir ER	Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes.	Investigative ophthalmology and visual science	2012	31
23274896	16334	Bachar-Wikstrom E	Stimulation of autophagy improves endoplasmic reticulum stress-induced diabetes.	Diabetes	2013	43
8528241	16337	Accili D	Early neonatal death in mice homozygous for a null allele of the insulin receptor gene.	Nature genetics	1996	111
9844629	16337	Brüning JC	A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.	Molecular cell	1998	299
10025399	16337	Kulkarni RN	Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.	Cell	1999	240
10642598	16337	Kido Y	Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.	The Journal of clinical investigation	2000	94
12110165	16337	Blüher M	Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance.	Developmental cell	2002	182
12543978	16337	Blüher M	Extended longevity in mice lacking the insulin receptor in adipose tissue.	Science	2003	329
16460269	16337	Biddinger SB	From mice to men: insights into the insulin resistance syndromes.	Annual review of physiology	2006	180
16581003	16337	Han S	Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.	Cell metabolism	2006	95
17550779	16337	Könner AC	Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.	Cell metabolism	2007	176
17767907	16337	Matsumoto M	Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.	Cell metabolism	2007	176
18587407	16337	Biddinger SB	Hepatic insulin resistance directly promotes formation of cholesterol gallstones.	Nature medicine	2008	55
19933998	16337	Lin HV	Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons.	Diabetes	2010	52
20407209	16337	Shimizu I	Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents.	The Journal of clinical investigation	2010	48
20889126	16337	Welsh GI	Insulin signaling to the glomerular podocyte is critical for normal kidney function.	Cell metabolism	2010	90
21284985	16337	Scherer T	Brain insulin controls adipose tissue lipolysis and lipogenesis.	Cell metabolism	2011	58
22404968	16337	Tiganis T	PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis.	The FEBS journal	2013	26
25417115	16337	Gusarova V	ANGPTL8/betatrophin does not control pancreatic beta cell expansion.	Cell	2014	44
25733901	16337	Kleinridders A	Insulin resistance in brain alters dopamine turnover and causes behavioral disorders.	Proceedings of the National Academy of Sciences of the United States of America	2015	19
27941241	16337	Swisa A	PAX6 maintains β cell identity by repressing genes of alternative islet cell types.	The Journal of clinical investigation	2017	6
7526222	16367	Araki E	Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.	Nature	1994	239
7675087	16367	Sun XJ	Role of IRS-2 in insulin and cytokine signalling.	Nature	1995	135
8571133	16367	Hotamisligil GS	IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.	Science	1996	391
9038347	16367	Brüning JC	Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles.	Cell	1997	137
9495343	16367	Withers DJ	Disruption of IRS-2 causes type 2 diabetes in mice.	Nature	1998	319
11078455	16367	Kubota N	Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.	Diabetes	2000	96
12417588	16367	Lee YH	c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade.	The Journal of biological chemistry	2003	91
12904469	16367	Schubert M	Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation.	The Journal of neuroscience 	2003	108
15372107	16367	Kulkarni RN	PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance.	The Journal of clinical investigation	2004	86
15711641	16367	Taniguchi CM	Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.	The Journal of clinical investigation	2005	66
17928362	16367	Selman C	Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice.	FASEB journal 	2008	170
18590693	16367	Dong XC	Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.	Cell metabolism	2008	126
19066218	16367	Choi CS	Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2008	102
19605645	16367	Ma QL	Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.	The Journal of neuroscience 	2009	95
19759515	16367	Hu Z	Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice.	The Journal of clinical investigation	2009	54
21731668	16367	Macotela Y	Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism.	PloS one	2011	65
22405072	16367	Tsuchiya K	FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.	Cell metabolism	2012	49
23965929	16367	Yi JS	MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling.	Nature communications	2013	28
10953027	16835	Li AC	Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.	The Journal of clinical investigation	2000	161
16127462	16835	Vikramadithyan RK	Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.	The Journal of clinical investigation	2005	66
16873680	16835	Zang M	Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.	Diabetes	2006	162
17932314	16835	Al-Aly Z	Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.	Arteriosclerosis, thrombosis, and vascular biology	2007	88
18249172	16835	Biddinger SB	Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.	Cell metabolism	2008	138
19478200	16835	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	46
21690266	16835	Subramanian S	Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.	Journal of lipid research	2011	50
21703998	16835	Van Rooyen DM	Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis.	Gastroenterology	2011	49
7984236	16846	Zhang Y	Positional cloning of the mouse obese gene and its human homologue.	Nature	1994	1679
9392508	16846	Schwartz MW	Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus.	Diabetes	1997	118
10485707	16846	Shimomura I	Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.	Nature	1999	168
11533494	16846	Yuan M	Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.	Science	2001	421
11877467	16846	McPherron AC	Suppression of body fat accumulation in myostatin-deficient mice.	The Journal of clinical investigation	2002	120
11970899	16846	Cheng A	Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.	Developmental cell	2002	112
12618528	16846	Matsusue K	Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.	The Journal of clinical investigation	2003	130
14976145	16846	Fu L	Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.	Endocrinology	2004	126
15306821	16846	Um SH	Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.	Nature	2004	486
15983201	16846	Rahmouni K	Role of selective leptin resistance in diet-induced obesity hypertension.	Diabetes	2005	83
16293343	16846	Farr SA	Effects of leptin on memory processing.	Peptides	2006	92
16679295	16846	Sun Y	Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice.	Cell metabolism	2006	81
16790840	16846	Wang Y	Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.	Journal of lipid research	2006	67
17416903	16846	Crunkhorn S	Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation.	The Journal of biological chemistry	2007	71
17909097	16846	Kim YD	Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.	Diabetes	2008	92
18256137	16846	Stratigopoulos G	Regulation of Fto/Ftm gene expression in mice and humans.	American journal of physiology. Regulatory, integrative and comparative physiology	2008	94
20739548	16846	Louis GW	Direct innervation and modulation of orexin neurons by lateral hypothalamic LepRb neurons.	The Journal of neuroscience 	2010	44
20929977	16846	Li L	Mitochondrial biogenesis and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) deacetylation by physical activity: intact adipocytokine signaling is required.	Diabetes	2011	38
21427219	16846	Louis GW	Molecular mapping of the neural pathways linking leptin to the neuroendocrine reproductive axis.	Endocrinology	2011	35
21633176	16846	Gautron L	Sixteen years and counting: an update on leptin in energy balance.	The Journal of clinical investigation	2011	112
21865462	16846	Enriori PJ	Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance.	The Journal of neuroscience 	2011	82
22201680	16846	McNay DE	Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice.	The Journal of clinical investigation	2012	72
23663742	16846	Holland WL	An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.	Cell metabolism	2013	101
24011077	16846	Fujikawa T	Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin.	Cell metabolism	2013	32
24880214	16846	Kim JG	Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding.	Nature neuroscience	2014	43
25480301	16846	Simonds SE	Leptin mediates the increase in blood pressure associated with obesity.	Cell	2014	37
8608603	16847	Chen H	Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice.	Cell	1996	351
16284652	16847	de Luca C	Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes.	The Journal of clinical investigation	2005	141
17200442	16847	Gao X	Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice.	Circulation	2007	81
17268472	16847	Yamauchi T	Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.	Nature medicine	2007	287
17726024	16847	Gong Y	The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms.	The Journal of biological chemistry	2007	55
17909627	16847	Morioka T	Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice.	The Journal of clinical investigation	2007	73
19279251	16847	Leshan RL	Direct innervation of GnRH neurons by metabolic- and sexual odorant-sensing leptin receptor neurons in the hypothalamic ventral premammillary nucleus.	The Journal of neuroscience 	2009	70
19478208	16847	Zhang H	Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress.	Arteriosclerosis, thrombosis, and vascular biology	2009	62
20374961	16847	Hill JW	Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility.	Cell metabolism	2010	134
20410123	16847	Leshan RL	Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala.	The Journal of neuroscience 	2010	51
21907138	16847	Leinninger GM	Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance.	Cell metabolism	2011	83
24153306	16847	Liu S	A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use.	Nature	2013	50
19007787	18024	He X	Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes.	Journal of molecular and cellular cardiology	2009	64
20103708	18024	Jiang T	The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy.	Diabetes	2010	73
20418481	18024	Ungvari Z	Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.	American journal of physiology. Heart and circulatory physiology	2010	94
21217061	18024	Ungvari Z	Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia.	American journal of physiology. Heart and circulatory physiology	2011	46
21852674	18024	Chartoumpekis DV	Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice.	Diabetes	2011	40
21873646	18024	Xu X	Long-term exposure to ambient fine particulate pollution induces insulin resistance and mitochondrial alteration in adipose tissue.	Toxicological sciences 	2011	42
22025779	18024	Zheng H	Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy.	Diabetes	2011	80
22936178	18024	Xu J	Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.	Diabetes	2012	34
23353773	18024	Bai Y	Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.	Journal of molecular and cellular cardiology	2013	35
23716596	18024	Uruno A	The Keap1-Nrf2 system prevents onset of diabetes mellitus.	Molecular and cellular biology	2013	38
24186494	18024	Xu Z	NRF2 plays a protective role in diabetic retinopathy in mice.	Diabetologia	2014	26
24186865	18024	Yagishita Y	Nrf2 protects pancreatic β-cells from oxidative and nitrosative stress in diabetic model mice.	Diabetes	2014	23
24958099	18024	Meakin PJ	Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance.	Molecular and cellular biology	2014	22
25967870	18024	Bell KF	Neuronal development is promoted by weakened intrinsic antioxidant defences due to epigenetic repression of Nrf2.	Nature communications	2015	20
7545787	18127	Huang PL	Hypertension in mice lacking the gene for endothelial nitric oxide synthase.	Nature	1995	351
11901190	18127	Zou MH	Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite.	The Journal of clinical investigation	2002	148
15265871	18127	Zou MH	Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species.	The Journal of biological chemistry	2004	126
16971655	18127	Zhao HJ	Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.	Journal of the American Society of Nephrology 	2006	106
17255104	18127	Wu Y	Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase.	The Journal of biological chemistry	2007	97
17456755	18127	Kanetsuna Y	Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.	The American journal of pathology	2007	64
21030723	18127	Giacco F	Oxidative stress and diabetic complications.	Circulation research	2010	590
21045790	18127	Nakagawa T	Endothelial dysfunction as a potential contributor in diabetic nephropathy.	Nature reviews. Nephrology	2011	47
22896587	18127	Sansbury BE	Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype.	Circulation research	2012	31
22997257	18127	Yuen DA	eNOS deficiency predisposes podocytes to injury in diabetes.	Journal of the American Society of Nephrology 	2012	33
9637677	18609	Ahlgren U	beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes.	Genes and development	1998	227
10580429	18609	Kaneto H	Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity.	Diabetes	1999	101
11781323	18609	Brissova M	Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion.	The Journal of biological chemistry	2002	117
12697734	18609	Johnson JD	Increased islet apoptosis in Pdx1+/- mice.	The Journal of clinical investigation	2003	113
16418487	18609	Fujitani Y	Targeted deletion of a cis-regulatory region reveals differential gene dosage requirements for Pdx1 in foregut organ differentiation and pancreas formation.	Genes and development	2006	70
19237535	18609	Evans-Molina C	Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure.	Molecular and cellular biology	2009	59
19855005	18609	Sachdeva MM	Pdx1 (MODY4) regulates pancreatic beta cell susceptibility to ER stress.	Proceedings of the National Academy of Sciences of the United States of America	2009	66
20802254	18609	Wicksteed B	Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain.	Diabetes	2010	120
20813264	18609	Kobayashi T	Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells.	Cell	2010	83
25470546	18609	Brouwers B	Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression.	Cell metabolism	2014	31
11781357	19013	Finck BN	The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.	The Journal of clinical investigation	2002	212
12552126	19013	Finck BN	A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content.	Proceedings of the National Academy of Sciences of the United States of America	2003	133
15107844	19013	Koo SH	PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.	Nature medicine	2004	155
16054054	19013	Finck BN	A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.	Cell metabolism	2005	79
16306350	19013	Tsuchida A	Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.	Diabetes	2005	71
17130488	19013	Wolins NE	OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.	Diabetes	2006	99
17261654	19013	Duncan JG	Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.	Circulation	2007	67
17601491	19013	Lundåsen T	PPARalpha is a key regulator of hepatic FGF21.	Biochemical and biophysical research communications	2007	92
18037994	19013	Burkart EM	Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.	The Journal of clinical investigation	2007	86
18462747	19013	Madrazo JA	The PPAR trio: regulators of myocardial energy metabolism in health and disease.	Journal of molecular and cellular cardiology	2008	80
19451348	19013	Yan J	Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.	Circulation	2009	52
20089785	19013	Takikawa M	Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice.	The Journal of nutrition	2010	66
22005518	19013	Woo CC	Thymoquinone: potential cure for inflammatory disorders and cancer.	Biochemical pharmacology	2012	49
22722857	19013	Cipolletta D	PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells.	Nature	2012	191
23134073	19013	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	37
23676496	19013	Gan Z	Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism.	The Journal of clinical investigation	2013	49
24167256	19013	Wang F	Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ.	Proceedings of the National Academy of Sciences of the United States of America	2013	40
24482374	19013	Cheang WS	Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.	Arteriosclerosis, thrombosis, and vascular biology	2014	27
24506873	19013	Adamovich Y	Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides.	Cell metabolism	2014	44
25383539	19013	Lee JM	Nutrient-sensing nuclear receptors coordinate autophagy.	Nature	2014	63
25695945	19013	den Besten G	Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation.	Diabetes	2015	40
27071062	19013	Stec DE	Bilirubin Binding to PPARα Inhibits Lipid Accumulation.	PloS one	2016	10
8647948	19016	Vidal-Puig A	Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.	The Journal of clinical investigation	1996	125
10878750	19016	Moller DE	Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.	Trends in endocrinology and metabolism	2000	100
12805374	19016	Gavrilova O	Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.	The Journal of biological chemistry	2003	185
12925701	19016	Norris AW	Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.	The Journal of clinical investigation	2003	108
15249658	19016	Zhang J	Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.	Proceedings of the National Academy of Sciences of the United States of America	2004	70
15956187	19016	Zhang H	Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.	Proceedings of the National Academy of Sciences of the United States of America	2005	92
16326714	19016	Nawrocki AR	Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists.	The Journal of biological chemistry	2006	200
16608888	19016	Schwartz AV	Thiazolidinedione use and bone loss in older diabetic adults.	The Journal of clinical endocrinology and metabolism	2006	92
17442990	19016	Govindarajan R	Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.	Journal of clinical oncology 	2007	100
17515919	19016	Odegaard JI	Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.	Nature	2007	537
18276926	19016	Duan SZ	Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.	Circulation research	2008	68
18316027	19016	Halabi CM	Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.	Cell metabolism	2008	72
18845632	19016	Sarruf DA	Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis.	Endocrinology	2009	48
19065047	19016	Kanda T	PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice.	The Journal of clinical investigation	2009	54
19147827	19016	Wu M	Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.	The American journal of pathology	2009	65
19589179	19016	Fujiki K	Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes.	BMC biology	2009	59
19906798	19016	Kliewer SA	Fibroblast growth factor 21: from pharmacology to physiology.	The American journal of clinical nutrition	2010	69
20097754	19016	Schopfer FJ	Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.	The Journal of biological chemistry	2010	53
21532596	19016	Lu M	Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.	Nature medicine	2011	77
12754525	19017	Puigserver P	Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.	Nature	2003	363
17053067	19017	Sandri M	PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription.	Proceedings of the National Academy of Sciences of the United States of America	2006	246
17932564	19017	Handschin C	Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk.	The Journal of clinical investigation	2007	122
19366864	19017	Gao Z	Butyrate improves insulin sensitivity and increases energy expenditure in mice.	Diabetes	2009	164
19542201	19017	Bugger H	Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice.	Diabetes	2009	51
22252943	19017	Holmström MH	Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes.	American journal of physiology. Endocrinology and metabolism	2012	32
24430439	19017	Laker RC	Exercise prevents maternal high-fat diet-induced hypermethylation of the Pgc-1α gene and age-dependent metabolic dysfunction in the offspring.	Diabetes	2014	20
26435323	19017	Dong J	Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues.	International journal of obesity	2016	12
26950361	19017	Jang C	A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance.	Nature medicine	2016	23
10066179	19246	Elchebly M	Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.	Science	1999	360
16845389	19246	Bence KK	Neuronal PTP1B regulates body weight, adiposity and leptin action.	Nature medicine	2006	166
18281274	19246	Zabolotny JM	Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.	The Journal of biological chemistry	2008	88
19074988	19246	Delibegovic M	Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress.	Diabetes	2009	74
16034410	19662	Yang Q	Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.	Nature	2005	430
16775236	19662	Graham TE	Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.	The New England journal of medicine	2006	264
22431523	19662	Norseen J	Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism.	Molecular and cellular biology	2012	56
24606904	19662	Moraes-Vieira PM	RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance.	Cell metabolism	2014	39
16410358	20186	Zhang Y	Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	178
16446356	20186	Cariou B	The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.	The Journal of biological chemistry	2006	99
19126757	20186	Lefebvre P	Role of bile acids and bile acid receptors in metabolic regulation.	Physiological reviews	2009	261
21593203	20186	Prawitt J	Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.	Diabetes	2011	63
21632533	20186	Watanabe M	Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.	The Journal of biological chemistry	2011	55
24670636	20186	Ryan KK	FXR is a molecular target for the effects of vertical sleeve gastrectomy.	Nature	2014	127
26670557	20186	Jiang C	Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.	Nature communications	2015	24
14654089	20249	Ntambi JM	Regulation of stearoyl-CoA desaturases and role in metabolism.	Progress in lipid research	2004	110
15855315	20249	Biddinger SB	Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome.	Diabetes	2005	79
18460915	20249	Flowers MT	Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.	Current opinion in lipidology	2008	80
19066317	20249	Paton CM	Biochemical and physiological function of stearoyl-CoA desaturase.	American journal of physiology. Endocrinology and metabolism	2009	84
11137992	20371	Wildin RS	X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.	Nature genetics	2001	427
17878367	20371	DiPaolo RJ	Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells.	Journal of immunology	2007	72
18725525	20371	Zhou X	Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity.	The Journal of experimental medicine	2008	189
19633656	20371	Feuerer M	Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.	Nature medicine	2009	456
21690251	20371	Daniel C	Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope.	The Journal of experimental medicine	2011	39
22579475	20371	Darce J	An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes.	Immunity	2012	43
22579476	20371	Bettini ML	Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.	Immunity	2012	54
23804561	20371	Shin NR	An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.	Gut	2014	123
25863247	20371	Kolodin D	Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice.	Cell metabolism	2015	38
26872699	20371	Kuswanto W	Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells.	Immunity	2016	21
12639990	20526	Ianus A	In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion.	The Journal of clinical investigation	2003	103
16377570	20526	Ohtsubo K	Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes.	Cell	2005	104
25421524	20526	Thorens B	GLUT2, glucose sensing and glucose homeostasis.	Diabetologia	2015	28
10932232	20528	Zisman A	Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.	Nature medicine	2000	142
11217863	20528	Abel ED	Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.	Nature	2001	237
20093359	20528	Herman MA	Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels.	The Journal of biological chemistry	2010	61
22466288	20528	Herman MA	A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.	Nature	2012	120
23139350	20528	Keung W	Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice.	Diabetes	2013	28
23630302	20528	Dai C	Pancreatic islet vasculature adapts to insulin resistance through dilation and not angiogenesis.	Diabetes	2013	28
22124465	20537	Gorboulev V	Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.	Diabetes	2012	96
22355316	20537	Liang Y	Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.	PloS one	2012	43
23149623	20537	Powell DR	Improved glycemic control in mice lacking Sglt1 and Sglt2.	American journal of physiology. Endocrinology and metabolism	2013	26
24226519	20537	Rieg T	Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.	American journal of physiology. Renal physiology	2014	27
24226524	20537	Vallon V	SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.	American journal of physiology. Renal physiology	2014	41
25616707	20537	Gallo LA	Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.	Diabetes and vascular disease research	2015	21
8790408	20656	Lebovitz RM	Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1996	216
16505246	20656	Shen X	Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy.	Diabetes	2006	99
17015165	20656	Kowluru RA	Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress.	Free radical biology and medicine	2006	70
17652755	20656	Kanwar M	Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.	Investigative ophthalmology and visual science	2007	98
19805130	20656	Hoehn KL	Insulin resistance is a cellular antioxidant defense mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2009	134
21060152	20656	Marrotte EJ	Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice.	The Journal of clinical investigation	2010	50
24135141	20656	Dugan LL	AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function.	The Journal of clinical investigation	2013	74
24985474	20656	Mao H	Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration.	Investigative ophthalmology and visual science	2014	21
25759382	20656	Cheung KG	Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes.	The Journal of biological chemistry	2015	18
10514488	20787	Shimomura I	Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus.	The Journal of biological chemistry	1999	155
17107947	20787	Cha JY	The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.	The Journal of biological chemistry	2007	109
18840786	20787	Xu J	Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.	Diabetes	2009	230
20817729	20787	Ponugoti B	SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.	The Journal of biological chemistry	2010	111
21459323	20787	Li Y	AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.	Cell metabolism	2011	203
22682225	20787	Haas JT	Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression.	Cell metabolism	2012	47
16308421	20869	Shaw RJ	The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.	Science	2005	494
16966378	20869	Koh HJ	Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3.	Molecular and cellular biology	2006	77
18482975	20869	Hou X	SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.	The Journal of biological chemistry	2008	210
20577053	20869	Foretz M	Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.	The Journal of clinical investigation	2010	251
21606593	20869	Miller RA	Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling.	The Journal of clinical investigation	2011	42
17283342	22227	Almind K	Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice.	Proceedings of the National Academy of Sciences of the United States of America	2007	85
17623815	22227	Boudina S	Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins.	Diabetes	2007	164
24150604	22227	Zhang Y	Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling.	Diabetes	2014	73
24789919	22227	Carrière A	Browning of white adipose cells by intermediate metabolites: an adaptive mechanism to alleviate redox pressure.	Diabetes	2014	29
26496606	22227	Kazak L	A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat.	Cell	2015	39
12086877	22339	Inoue M	VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.	Cancer cell	2002	83
12651605	22339	Wendt TM	RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.	The American journal of pathology	2003	90
17065333	22339	Brissova M	Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function.	Diabetes	2006	101
17202420	22339	Nakagawa T	Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.	Journal of the American Society of Nephrology 	2007	102
20501654	22339	Long J	Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.	The Journal of biological chemistry	2010	82
20530741	22339	Wang J	Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage.	Diabetes	2010	65
22451920	22339	Sun K	Dichotomous effects of VEGF-A on adipose tissue dysfunction.	Proceedings of the National Academy of Sciences of the United States of America	2012	88
22522611	22339	Elias I	Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance.	Diabetes	2012	58
20160352	22393	Fonseca SG	Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells.	The Journal of clinical investigation	2010	89
12447443	26419	Hirosumi J	A central role for JNK in obesity and insulin resistance.	Nature	2002	757
15448687	26419	Kaneto H	Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide.	Nature medicine	2004	80
16036612	26419	Karin M	From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.	IUBMB life	2005	120
17050683	26419	Solinas G	Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates.	Proceedings of the National Academy of Sciences of the United States of America	2006	75
17983584	26419	Solinas G	JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity.	Cell metabolism	2007	185
19136991	26419	Hotamisligil GS	Inflammation and endoplasmic reticulum stress in obesity and diabetes.	International journal of obesity	2008	77
19841069	26419	Sabio G	Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance.	Molecular and cellular biology	2010	43
20452774	26419	Sabio G	cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.	Trends in biochemical sciences	2010	42
21540183	26419	Gao Z	Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity.	The Journal of biological chemistry	2011	49
21962514	26419	Holzer RG	Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation.	Cell	2011	63
11696581	56458	Nakae J	The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression.	The Journal of clinical investigation	2001	173
12219087	56458	Nakae J	Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1.	Nature genetics	2002	172
12530968	56458	Nakae J	The forkhead transcription factor Foxo1 regulates adipocyte differentiation.	Developmental cell	2003	189
15272020	56458	Kamei Y	Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.	The Journal of biological chemistry	2004	140
16642023	56458	Hashimoto N	Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass.	Nature genetics	2006	64
18162510	56458	Nakae J	Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure.	Diabetes	2008	53
18174526	56458	Martinez SC	Inhibition of Foxo1 protects pancreatic islet beta-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis.	Diabetes	2008	55
22326951	56458	Battiprolu PK	Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.	The Journal of clinical investigation	2012	70
25141178	56458	Chera S	Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers.	Nature	2014	64
25963540	56458	O-Sullivan I	FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.	Nature communications	2015	17
15902306	56636	Kharitonenkov A	FGF-21 as a novel metabolic regulator.	The Journal of clinical investigation	2005	414
19819944	56636	Badman MK	Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.	Endocrinology	2009	104
20616029	56636	Chau MD	Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway.	Proceedings of the National Academy of Sciences of the United States of America	2010	83
23667629	56636	Kim KH	Acute exercise induces FGF21 expression in mice and in healthy humans.	PloS one	2013	27
23766126	56636	Camporez JP	Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice.	Endocrinology	2013	34
24401271	56636	Emanuelli B	Interplay between FGF21 and insulin action in the liver regulates metabolism.	The Journal of clinical investigation	2014	47
25008183	56636	Markan KR	Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.	Diabetes	2014	55
25024372	56636	Liang Q	FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.	Diabetes	2014	25
25924103	56636	Douris N	Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice.	Endocrinology	2015	19
26654352	56636	Fisher FM	Understanding the Physiology of FGF21.	Annual review of physiology	2016	19
26724858	56636	von Holstein-Rathlou S	FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver.	Cell metabolism	2016	18
11201732	57264	Steppan CM	The hormone resistin links obesity to diabetes.	Nature	2001	631
14976316	57264	Banerjee RR	Regulation of fasted blood glucose by resistin.	Science	2004	132
18005249	93759	Ramsey KM	Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice.	Aging cell	2008	91
18840364	93759	Banks AS	SirT1 gain of function increases energy efficiency and prevents diabetes in mice.	Cell metabolism	2008	234
19262508	93759	Cantó C	AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.	Nature	2009	620
19284563	93759	Smith JJ	Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo.	BMC systems biology	2009	77
19429820	93759	Csiszar A	Resveratrol induces mitochondrial biogenesis in endothelial cells.	American journal of physiology. Heart and circulatory physiology	2009	101
20008278	93759	Sulaiman M	Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.	American journal of physiology. Heart and circulatory physiology	2010	50
21102633	93759	Herranz D	SIRT1: recent lessons from mouse models.	Nature reviews. Cancer	2010	86
21261652	93759	Agarwal B	Resveratrol and life extension.	Annals of the New York Academy of Sciences	2011	41
21321189	93759	Li Y	Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver.	FASEB journal 	2011	75
21907137	93759	Ramadori G	SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance.	Cell metabolism	2011	50
21985785	93759	Schenk S	Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction.	The Journal of clinical investigation	2011	56
22110092	93759	Gillum MP	SirT1 regulates adipose tissue inflammation.	Diabetes	2011	51
22908267	93759	Cai W	Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.	Proceedings of the National Academy of Sciences of the United States of America	2012	44
11956156	100705	Tomlinson E	Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity.	Endocrinology	2002	111
12920182	100705	Abu-Elheiga L	Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets.	Proceedings of the National Academy of Sciences of the United States of America	2003	87
15968460	100705	Tong L	Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery.	Cellular and molecular life sciences 	2005	77
17923673	100705	Choi CS	Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity.	Proceedings of the National Academy of Sciences of the United States of America	2007	96
24185692	100705	Fullerton MD	Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.	Nature medicine	2013	84
9867845	103988	Postic C	Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.	The Journal of biological chemistry	1999	378
17200721	103988	Terauchi Y	Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.	The Journal of clinical investigation	2007	98
23778137	103988	Hua H	iPSC-derived β cells model diabetes due to glucokinase deficiency.	The Journal of clinical investigation	2013	29
16443786	105787	Davis BJ	Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase.	Diabetes	2006	107
17855357	105787	Göransson O	Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase.	The Journal of biological chemistry	2007	111
19934007	105787	Um JH	AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol.	Diabetes	2010	176
25484077	105787	Song YM	Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.	Autophagy	2015	20
23979972	107221	Hudson BD	The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism.	Molecular pharmacology	2013	28
24997608	107221	Oh DY	A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.	Nature medicine	2014	27
15855317	108079	Foretz M	Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver.	Diabetes	2005	85
17513699	108079	Röckl KS	Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift.	Diabetes	2007	73
17671657	108079	Claret M	AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons.	The Journal of clinical investigation	2007	154
18835932	108079	Xie Z	Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes.	Diabetes	2008	52
19188503	108079	Wang Y	AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin.	Circulation	2009	49
20167927	108079	Wang S	AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.	Circulation research	2010	103
20299472	108079	Dong Y	Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo.	Diabetes	2010	49
24887203	108079	Pedrós I	Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.	Biochimica et biophysica acta	2014	21
7566151	109648	Stephens TW	The role of neuropeptide Y in the antiobesity action of the obese gene product.	Nature	1995	135
8603777	109648	Schwartz MW	Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.	Diabetes	1996	118
17261674	109648	Fioramonti X	Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks?	Diabetes	2007	57
20855609	109648	Fujikawa T	Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice.	Proceedings of the National Academy of Sciences of the United States of America	2010	61
25202980	109648	Secher A	The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.	The Journal of clinical investigation	2014	55
18227068	109801	Ceradini DJ	Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice.	The Journal of biological chemistry	2008	57
19833897	109801	Yao D	Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands.	Diabetes	2010	88
24062246	109801	Giacco F	Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice.	Diabetes	2014	21
19325873	230796	Jo J	Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth.	PLoS computational biology	2009	114
24146030	230796	Bartelt A	Adipose tissue browning and metabolic health.	Nature reviews. Endocrinology	2014	98
28199304	230796	Thomou T	Adipose-derived circulating miRNAs regulate gene expression in other tissues.	Nature	2017	14
16054069	233081	Steneberg P	The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse.	Cell metabolism	2005	87
17395749	233081	Latour MG	GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo.	Diabetes	2007	69
20955703	233081	Liou AP	The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin.	Gastroenterology	2011	49
19542200	239436	Nicolson TJ	Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants.	Diabetes	2009	108
19706465	239436	Lemaire K	Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	78
20424817	239436	Wijesekara N	Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion.	Diabetologia	2010	73
11014193	384783	Burks DJ	IRS-2 pathways integrate female reproduction and energy homeostasis.	Nature	2000	94
15467829	384783	Lin X	Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes.	The Journal of clinical investigation	2004	85
15841180	384783	Choudhury AI	The role of insulin receptor substrate 2 in hypothalamic and beta cell function.	The Journal of clinical investigation	2005	91
19838201	384783	Cheng Z	Foxo1 integrates insulin signaling with mitochondrial function in the liver.	Nature medicine	2009	76
21356519	384783	Kubota T	Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle.	Cell metabolism	2011	98
21926467	384783	Sadagurski M	IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease.	The Journal of clinical investigation	2011	37
23478411	384783	Jain S	Chronic activation of a designer G(q)-coupled receptor improves β cell function.	The Journal of clinical investigation	2013	30
